Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1235293572
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave, Taussig Cancer Institute R35
Cleveland, OH, 44195
Phone (216) 444-2529
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
468 services
Medicare patients, 2024
72
Average age 69
Drug cost, 2024
$3.5M
1,425 prescriptions
Company payments, 2025
$4,691
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Betty K Hamilton was code 99233 (hospital e&m - subsequent), 155 times for 23 patients. In total Betty K Hamilton billed 468 services in 16 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 155 | 23 | $83.95 | $13K |
| 99214 Office E&M - Established | Facility | 136 | 46 | $67.57 | $9,190 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 123 | 48 | $12.29 | $1,511 |
| 99213 Office E&M - Established | Facility | 15 | 12 | $46.57 | $699 |
By year: 2022 $28K for 376 services; 2023 $33K for 410 services; 2024 $27K for 468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Betty K Hamilton prescribed most often to Medicare patients was Acyclovir, with 173 prescriptions and refills. In total Betty K Hamilton wrote 1,425 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 173 | 258 | 34 | $1,761 |
| Jakafi Ruxolitinib Phosphate | 83 | 83 | 11 | $1.2M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 70 | 103 | 19 | $272 |
| Pantoprazole Sodium Generic | 65 | 105 | 15 | $425 |
| Rezurock Belumosudil Mesylate | 63 | 63 | Under 11 | $2.0M |
| Amoxicillin Generic | 47 | 67 | 17 | $162 |
| Rosuvastatin Calcium Generic | 46 | 100 | 13 | $314 |
| Gabapentin Generic | 43 | 50 | Under 11 | $565 |
| Dexamethasone Generic | 43 | 46 | 12 | $1,090 |
| Fluconazole Generic | 35 | 49 | Under 11 | $1,127 |
| Posaconazole Generic | 29 | 29 | Under 11 | $64K |
| Budesonide Dr Budesonide | 28 | 31 | Under 11 | $3,599 |
| Tacrolimus Generic | 28 | 37 | Under 11 | $1,223 |
| Azithromycin Generic | 27 | 56 | Under 11 | $721 |
| Potassium Chloride Generic | 26 | 45 | Under 11 | $518 |
Brand drugs: 250 claims; generic drugs: 1,175 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Betty K Hamilton $4,691 ($4,691 in general payments such as food, travel and fees) from 6 companies. The largest payer was CSL Behring with $2,925.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.